原来如此啊：Amyris (NASDAQ:AMRS) has signed an exclusive license with Nant Africa relating to the development and use of its RNA COVID vaccine developed in coordination with the Infectious Disease Research Institute (IDRI).The license and collaboration is expected to generate several million dollars in near term upfront and milestone payments, and also includes long term royalties for the use of the Amyris and IDRI technology on the African continent, the company said.It also includes the funding of human clinical trials, which upon successful completion are expected to be followed by the production and scaling of the vaccine in South Africa with a target of reaching patients by the end of this year.Amyris highlighted that it continues to hold options to license exclusive use of this RNA technology for selected oncology and other target therapies.Shares up nearly 3% premarket.

等到10点半看看😀

设套没必要，小钱也是钱